SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition

Patented annatto extract of delta tocotrienol bolsters heart healthy ingredient position

CHICAGO – SourceOne™ Global Partners has announced it has made a commitment to form a joint venture agreement with American River Nutrition. SourceOne will provide marketing and sales expertise to the scientific support, product development and manufacturing expertise of American River Nutrition. Dr. Barrie Tan and American River Nutrition hold multiple patents and patents pending for the DeltaGold® annatto extract, the most important and powerful natural vitamin E isomer for cholesterol reduction, healthy triglyceride levels, antioxidant activity and more.

Jesse Lopez, founder, president and CEO of SourceOne, comments, “This relationship between Dr. Barrie Tan and his patented annatto extract ingredient is highly complementary to our patented Sytrinol™ product and patent-pending Sytrinol™ and plant sterol combination. The marketplace is demanding a more balanced natural vitamin E and this partnership enables us to deliver to our customers an appropriate spectrum natural vitamin E that reflects the nutrient profile found in the foods we consume.”

Lopez notes that the addition of the patented annatto tocotrienol to SourceOne’s superior portfolio of cardiovascular wellness compounds elevates the company’s strategic market positioning in the heart health category. In addition to Sytrinol™ and Sytrinol™-plant sterols, SourceOne is also the exclusive marketing partner for the Ginnovay™ line of IP, non-GMO natural vitamin E products that includes palm tocotrienols, gamma tocopherols, rice tocotrienols and plant sterols. “Cardiovascular wellness continues to be one of the top concerns among the populace,” Lopez states. “The nutraceuticals industry must continue to respond with evolutionary formulas that provide efficacy and safety and that reflect the considerable and fast-paced scientific research on these compounds. We are very proud to be able to work with Dr. Tan, as he is renowned in the industry as an expert in tocotrienols and carotenoids.”

Dr. Barrie Tan, founder and president of American River Nutrition, stated, “We have known for some time that the desmethyl form of both tocotrienol and tocopherol was the key to delivering superior health benefits. Our patent application has been published for compositions and methods of use of annatto including tocotrienols and tocopherols with an appropriate spectrum. This spectrum includes, but is not limited to, low alpha tocopherol, high delta and gamma tocopherols, high delta and gamma tocotrienols and mixtures with other extracts and/or nutrients. We now have the marketing expertise of SourceOne to take this scientific breakthrough to the next level by creating the DeltaSource™ brand and building awareness of the many solutions this partnership delivers to the heart health conscious consumer.”

About SourceOne(TM) Global Partners
SourceOne was conceived as a company whose core competence is to integrate legitimate science with strong trade and consumer branding. SourceOne™ Global Partners cultivates relationships with leading suppliers worldwide to source and offer patented ingredients supported by proprietary science as part of a turnkey marketing program that dramatically increases the odds for marketing success.

About American River Nutrition
American River Nutrition, Inc. (ARN) was founded in 1998 by Dr. Barrie Tan. The company responds to the market need for innovative evidence-based products, which positively affect the outcome of age-related and/or degenerative diseases such as cardiovascular, prediabetes, diabetes and cancer. ARN focuses primarily in the discovery, development and manufacture of nutraceuticals from natural sources. To maximize discovery process, ARN persists on searching effective new nutrients for use in the vitamin, mineral and supplement, food and beverage, animal health, drug and cosmetic market sectors. ARN has developed DeltaGold® tocotrienol, best-in-class tocopherols-free tocotrienols containing essentially desmethyl tocotrienols. ARN’s DeltaGold® manufacture, composition and method of use are covered by issued (USP # 6,350,453, EP #1235822) and pending (USP application # 20050037102; PCT/US2004/011366) patents.
For further information on SourceOne™ Global Partners, visit or contact Begüm Tümer at 312.321.8222 or [email protected].

Begüm Tümer
(312) 321-8222

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.